✨ New Arrivals Just Dropped!Explore
$157.50
Original: $449.99
-65%Bronchicine CAe 50x1ml VIals Canine Vaccine—
$449.99
$157.50The Story
Prescription items and vaccines are NON-RETURNABLE and NON REFUNDABLE
**Vaccine orders are shipped Monday, Tuesday, and Wednesday via 2 day shipping.**
**All vaccines are shipped using a container and ice packs to keep products cool during shipping.**
**All vaccines shipping to the state of Minnesota require a written prescription.**
**CURRENT EXPIRATION DATE 05/11/2022**
Bronchicine CAe 50 x 1 Canine Vaccine
The Bronchicine CAe 50 x 1 Canine Vaccine is approved for healthy dogs 8 weeks of age or older to help control canine infectious trachebronchitis (kennel cough) caused by Bordetella bronchiseptica.
Features:
- Protects against Bordetella bronchiseptica, the primary pathogen in Canine Infectious Respiratory Disease (CIRD)
- For healthy dogs 8 weeks of age or older
Item Specifications:
Please Note: This item is Non-Returnable and Non-Refundable.
Manufacturer:
Zoetis, Inc.
Size:
50 x 1 ds Tray
Active Ingredient:
Bordetella Bronchiseptica Bacterin, Cellular Antigen Extract
Directions for Use:
Injectable B. bronchiseptica vaccine.
Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 2-4 weeks apart. Annual revaccination with a single dose is recommended.
The effect of persisting B. bronchiseptica maternal antibody on the immune response in puppies to the bacterin has not been determined. Puppies from bitches immune to the organism usually have low antibody titers that are dissipated by 4-6 weeks of age. Although kennel cough is considered a disease of complex etiology, it can be reproduced by challenge with B. bronchiseptica alone. A close association and/or confinement of dogs facilitates spread of the disease syndrome. Antibiotic therapy has been shown to be generally unsuccessful in reducing or eliminating B. bronchiseptica in dogs.
Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 2-4 weeks apart. Annual revaccination with a single dose is recommended.
The effect of persisting B. bronchiseptica maternal antibody on the immune response in puppies to the bacterin has not been determined. Puppies from bitches immune to the organism usually have low antibody titers that are dissipated by 4-6 weeks of age. Although kennel cough is considered a disease of complex etiology, it can be reproduced by challenge with B. bronchiseptica alone. A close association and/or confinement of dogs facilitates spread of the disease syndrome. Antibiotic therapy has been shown to be generally unsuccessful in reducing or eliminating B. bronchiseptica in dogs.
Cautions:
Store at 2°-7°C (35° to 45°F)
Prolonged exposure to higher temperatures may adversely affect potency.
Do not freeze.
Use entire contents when first opened.
Sterilized syringes and needles should be used to administer this vaccine.
Transient local irritation at the site of injection, though rare, may occur subsequent to use of this product.
As with many vaccines, anaphylaxis may occur after use.
Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy
Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy
For additional Shipping and Product information please see clickable links listed under Downloadable Resources to the right.
Description
Prescription items and vaccines are NON-RETURNABLE and NON REFUNDABLE
**Vaccine orders are shipped Monday, Tuesday, and Wednesday via 2 day shipping.**
**All vaccines are shipped using a container and ice packs to keep products cool during shipping.**
**All vaccines shipping to the state of Minnesota require a written prescription.**
**CURRENT EXPIRATION DATE 05/11/2022**
Bronchicine CAe 50 x 1 Canine Vaccine
The Bronchicine CAe 50 x 1 Canine Vaccine is approved for healthy dogs 8 weeks of age or older to help control canine infectious trachebronchitis (kennel cough) caused by Bordetella bronchiseptica.
Features:
- Protects against Bordetella bronchiseptica, the primary pathogen in Canine Infectious Respiratory Disease (CIRD)
- For healthy dogs 8 weeks of age or older
Item Specifications:
Please Note: This item is Non-Returnable and Non-Refundable.
Manufacturer:
Zoetis, Inc.
Size:
50 x 1 ds Tray
Active Ingredient:
Bordetella Bronchiseptica Bacterin, Cellular Antigen Extract
Directions for Use:
Injectable B. bronchiseptica vaccine.
Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 2-4 weeks apart. Annual revaccination with a single dose is recommended.
The effect of persisting B. bronchiseptica maternal antibody on the immune response in puppies to the bacterin has not been determined. Puppies from bitches immune to the organism usually have low antibody titers that are dissipated by 4-6 weeks of age. Although kennel cough is considered a disease of complex etiology, it can be reproduced by challenge with B. bronchiseptica alone. A close association and/or confinement of dogs facilitates spread of the disease syndrome. Antibiotic therapy has been shown to be generally unsuccessful in reducing or eliminating B. bronchiseptica in dogs.
Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 2-4 weeks apart. Annual revaccination with a single dose is recommended.
The effect of persisting B. bronchiseptica maternal antibody on the immune response in puppies to the bacterin has not been determined. Puppies from bitches immune to the organism usually have low antibody titers that are dissipated by 4-6 weeks of age. Although kennel cough is considered a disease of complex etiology, it can be reproduced by challenge with B. bronchiseptica alone. A close association and/or confinement of dogs facilitates spread of the disease syndrome. Antibiotic therapy has been shown to be generally unsuccessful in reducing or eliminating B. bronchiseptica in dogs.
Cautions:
Store at 2°-7°C (35° to 45°F)
Prolonged exposure to higher temperatures may adversely affect potency.
Do not freeze.
Use entire contents when first opened.
Sterilized syringes and needles should be used to administer this vaccine.
Transient local irritation at the site of injection, though rare, may occur subsequent to use of this product.
As with many vaccines, anaphylaxis may occur after use.
Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy
Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy
For additional Shipping and Product information please see clickable links listed under Downloadable Resources to the right.
